Nifty
Sensex
:
:
14371.90
48878.54
-218.45 (-1.50%)
-746.22 (-1.50%)

Pharmaceuticals & Drugs - Domestic

Rating :
63/99

BSE: 531599 | NSE: FDC

301.70
22-Jan-2021
  • Open
  • High
  • Low
  • Previous Close
  •  312.00
  •  313.55
  •  300.30
  •  311.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  277040
  •  846.49
  •  379.00
  •  175.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 5,162.53
  • 16.67
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 5,136.01
  • 0.26%
  • 2.99

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.35%
  • 2.99%
  • 15.78%
  • FII
  • DII
  • Others
  • 6.41%
  • 3.75%
  • 1.72%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.57
  • 6.22
  • 7.73

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.85
  • 5.07
  • 5.26

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.79
  • 7.33
  • 11.45

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.57
  • 20.36
  • 19.39

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.98
  • 3.00
  • 2.84

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.94
  • 12.88
  • 12.66

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
371.39
346.12
7.30%
308.18
343.52
-10.29%
333.33
270.67
23.15%
321.22
256.17
25.39%
Expenses
265.68
272.25
-2.41%
204.60
265.04
-22.80%
304.04
227.62
33.57%
236.40
199.68
18.39%
EBITDA
105.72
73.87
43.12%
103.58
78.48
31.98%
29.29
43.05
-31.96%
84.82
56.49
50.15%
EBIDTM
28.47%
21.34%
33.61%
22.84%
8.79%
15.90%
26.41%
22.05%
Other Income
19.04
16.90
12.66%
27.97
9.79
185.70%
37.76
13.92
171.26%
31.03
13.98
121.96%
Interest
0.82
0.82
0.00%
0.75
0.81
-7.41%
0.99
0.36
175.00%
0.79
0.35
125.71%
Depreciation
9.65
9.57
0.84%
9.44
9.36
0.85%
9.32
7.90
17.97%
9.20
7.51
22.50%
PBT
114.29
80.38
42.19%
121.36
78.09
55.41%
56.73
47.61
19.16%
105.77
62.62
68.91%
Tax
26.43
25.97
1.77%
29.44
21.73
35.48%
0.86
11.21
-92.33%
31.51
16.54
90.51%
PAT
87.86
54.41
61.48%
91.92
56.36
63.09%
55.88
36.39
53.56%
74.25
46.08
61.13%
PATM
23.66%
15.72%
29.83%
16.41%
16.76%
13.44%
23.12%
17.99%
EPS
5.15
3.16
62.97%
5.36
3.21
66.98%
3.25
1.99
63.32%
4.34
2.61
66.28%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
1,334.12
1,344.19
1,090.70
1,075.07
1,013.87
994.32
889.31
845.85
772.83
710.54
711.67
Net Sales Growth
9.67%
23.24%
1.45%
6.04%
1.97%
11.81%
5.14%
9.45%
8.77%
-0.16%
 
Cost Of Goods Sold
388.63
425.72
345.14
352.08
339.05
357.93
272.91
266.16
311.11
237.54
253.93
Gross Profit
945.49
918.46
745.56
722.99
674.81
636.38
616.40
579.69
461.71
473.00
457.75
GP Margin
70.87%
68.33%
68.36%
67.25%
66.56%
64.00%
69.31%
68.53%
59.74%
66.57%
64.32%
Total Expenditure
1,010.72
1,051.25
859.68
848.38
770.40
765.58
690.76
641.47
591.97
547.15
545.76
Power & Fuel Cost
-
27.40
24.61
22.00
21.55
23.14
20.18
18.45
16.85
13.77
12.73
% Of Sales
-
2.04%
2.26%
2.05%
2.13%
2.33%
2.27%
2.18%
2.18%
1.94%
1.79%
Employee Cost
-
277.48
225.57
216.67
191.08
175.76
137.58
122.05
107.52
99.02
85.57
% Of Sales
-
20.64%
20.68%
20.15%
18.85%
17.68%
15.47%
14.43%
13.91%
13.94%
12.02%
Manufacturing Exp.
-
61.14
62.25
58.77
49.40
36.44
97.27
88.65
22.88
70.20
67.06
% Of Sales
-
4.55%
5.71%
5.47%
4.87%
3.66%
10.94%
10.48%
2.96%
9.88%
9.42%
General & Admin Exp.
-
58.06
59.45
61.55
53.35
49.97
41.43
35.99
34.32
33.79
31.76
% Of Sales
-
4.32%
5.45%
5.73%
5.26%
5.03%
4.66%
4.25%
4.44%
4.76%
4.46%
Selling & Distn. Exp.
-
94.70
78.92
75.96
64.36
57.73
64.96
58.43
56.15
55.45
55.12
% Of Sales
-
7.05%
7.24%
7.07%
6.35%
5.81%
7.30%
6.91%
7.27%
7.80%
7.75%
Miscellaneous Exp.
-
106.74
63.73
61.35
51.61
64.61
56.43
51.73
43.13
37.36
55.12
% Of Sales
-
7.94%
5.84%
5.71%
5.09%
6.50%
6.35%
6.12%
5.58%
5.26%
5.56%
EBITDA
323.41
292.94
231.02
226.69
243.47
228.74
198.55
204.38
180.86
163.39
165.91
EBITDA Margin
24.24%
21.79%
21.18%
21.09%
24.01%
23.00%
22.33%
24.16%
23.40%
23.00%
23.31%
Other Income
115.80
68.90
43.47
50.96
50.22
39.00
45.72
42.00
46.36
28.65
28.25
Interest
3.35
3.42
1.44
1.40
1.41
1.40
1.81
3.10
1.60
1.41
1.44
Depreciation
37.61
37.46
33.24
35.14
34.62
33.73
38.81
24.91
27.90
18.43
17.36
PBT
398.15
320.97
239.80
241.11
257.65
232.62
203.65
218.36
197.72
172.20
175.37
Tax
88.24
80.08
66.85
67.12
63.30
63.48
55.51
83.04
42.55
38.11
24.48
Tax Rate
22.16%
24.95%
28.01%
27.84%
25.14%
27.29%
27.26%
38.03%
21.52%
22.13%
13.96%
PAT
309.91
240.89
171.85
173.99
188.47
169.14
148.15
135.32
155.17
134.09
150.89
PAT before Minority Interest
309.93
240.89
171.85
173.99
188.47
169.14
148.15
135.32
155.17
134.09
150.89
Minority Interest
0.02
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
23.23%
17.92%
15.76%
16.18%
18.59%
17.01%
16.66%
16.00%
20.08%
18.87%
21.20%
PAT Growth
60.38%
40.17%
-1.23%
-7.68%
11.43%
14.17%
9.48%
-12.79%
15.72%
-11.13%
 
EPS
18.36
14.27
10.18
10.31
11.17
10.02
8.78
8.02
9.19
7.94
8.94

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
1,547.43
1,445.24
1,276.11
1,270.20
1,082.47
936.38
845.30
784.24
695.42
616.39
Share Capital
17.10
17.52
17.52
17.86
17.86
17.86
17.86
18.16
18.37
18.54
Total Reserves
1,530.33
1,427.72
1,258.59
1,252.34
1,064.61
918.52
827.43
766.08
677.05
597.86
Non-Current Liabilities
314.62
229.17
211.41
216.67
19.93
24.06
30.97
31.32
30.24
29.59
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.22
0.56
0.77
Unsecured Loans
0.34
0.49
0.60
0.69
0.79
0.90
1.07
1.24
1.45
1.73
Long Term Provisions
295.78
213.96
194.12
198.60
0.50
0.56
0.00
0.00
0.00
2.20
Current Liabilities
564.62
497.43
480.07
389.40
163.42
187.97
195.69
153.97
139.01
123.45
Trade Payables
117.86
77.61
97.32
75.10
82.59
87.17
80.05
61.04
57.64
45.90
Other Current Liabilities
80.06
61.67
68.78
64.11
50.16
36.61
42.87
35.98
30.09
29.60
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
1.00
1.11
1.14
1.29
1.27
Short Term Provisions
366.69
358.15
313.97
250.19
30.67
63.19
71.66
55.81
49.99
46.68
Total Liabilities
2,426.67
2,171.84
1,967.59
1,876.27
1,265.82
1,148.41
1,071.96
969.53
864.67
769.43
Net Block
673.50
682.19
673.64
678.05
675.16
393.04
284.40
289.19
293.04
276.74
Gross Block
844.97
817.80
776.49
745.84
708.81
629.67
470.42
453.02
430.01
396.15
Accumulated Depreciation
171.47
135.61
102.84
67.79
33.65
236.62
186.02
163.82
136.96
119.41
Non Current Assets
1,181.25
1,113.46
976.64
957.93
742.46
646.27
619.47
558.20
418.02
322.50
Capital Work in Progress
23.85
12.38
12.84
6.32
19.92
28.80
18.10
7.22
10.72
10.18
Non Current Investment
162.31
179.11
74.07
54.49
39.43
216.72
186.92
245.15
96.20
14.01
Long Term Loans & Adv.
320.83
239.08
215.28
218.46
7.70
6.37
128.71
15.13
17.41
19.42
Other Non Current Assets
0.75
0.71
0.81
0.60
0.25
1.33
1.33
1.51
0.65
2.15
Current Assets
1,245.41
1,058.38
990.94
918.34
523.36
502.13
452.03
410.83
446.10
446.88
Current Investments
502.24
405.93
397.16
436.53
285.41
272.49
229.90
170.91
243.92
248.86
Inventories
209.96
173.79
160.49
137.16
130.91
123.22
103.00
99.71
102.92
97.42
Sundry Debtors
123.74
87.53
81.66
76.06
61.94
61.04
59.36
43.23
41.97
40.75
Cash & Bank
32.32
21.26
29.30
28.47
18.02
14.95
23.43
36.50
16.78
17.76
Other Current Assets
377.15
11.32
10.68
9.68
27.10
30.44
36.33
60.49
40.52
42.09
Short Term Loans & Adv.
350.34
358.56
311.65
230.44
20.36
14.77
28.18
48.89
34.66
39.71
Net Current Assets
680.79
560.94
510.87
528.94
359.94
314.16
256.33
256.86
307.09
323.43
Total Assets
2,426.66
2,171.84
1,967.58
1,876.27
1,265.82
1,148.40
1,071.97
969.53
864.66
769.44

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
250.38
112.43
149.84
154.49
174.30
127.64
149.72
149.94
144.33
120.74
PBT
319.95
237.75
240.63
257.71
232.15
203.65
218.36
197.72
172.20
175.37
Adjustment
22.58
-0.21
0.39
-10.88
2.41
-1.40
-7.67
-14.20
-2.62
1.31
Changes in Working Capital
-7.77
-51.05
-23.24
-19.23
-4.54
-11.78
7.09
4.14
9.01
-20.98
Cash after chg. in Working capital
334.77
186.49
217.78
227.60
230.02
190.48
217.79
187.66
178.59
155.70
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-84.39
-74.06
-67.94
-70.14
-55.73
-62.84
-68.07
-37.72
-34.26
-34.97
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
-2.97
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-98.35
-120.33
20.11
-143.55
-73.05
-88.57
-55.38
-107.18
-108.25
-33.00
Net Fixed Assets
-38.52
-40.93
-36.71
-24.24
-81.62
-169.89
-28.28
-19.51
-25.53
-17.54
Net Investments
-79.51
-113.70
19.79
-166.18
170.44
-72.39
-0.76
-75.95
-83.31
-33.71
Others
19.68
34.30
37.03
46.87
-161.87
153.71
-26.34
-11.72
0.59
18.25
Cash from Financing Activity
-142.00
-0.07
-169.43
0.35
-96.98
-47.76
-75.25
-62.83
-58.18
-57.51
Net Cash Inflow / Outflow
10.03
-7.96
0.52
11.29
4.27
-8.69
19.09
-20.06
-22.10
30.22
Opening Cash & Equivalents
19.92
28.13
27.10
16.25
12.17
23.26
4.17
24.23
46.33
16.11
Closing Cash & Equivalent
29.88
19.92
28.13
27.10
16.25
14.56
23.26
4.17
24.23
46.33

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
90.51
82.86
73.17
71.42
60.87
52.62
47.47
43.30
37.95
33.35
ROA
10.48%
8.30%
9.05%
12.00%
14.01%
13.34%
13.26%
16.92%
16.41%
20.83%
ROE
16.10%
12.63%
13.67%
16.02%
16.76%
16.64%
16.63%
21.01%
20.48%
26.44%
ROCE
21.63%
17.64%
19.04%
21.51%
23.15%
23.02%
27.12%
26.85%
26.34%
30.73%
Fixed Asset Turnover
1.66
1.41
1.42
1.44
1.52
1.65
1.87
1.79
1.75
1.91
Receivable days
27.96
27.55
26.58
23.96
22.06
24.19
21.70
19.72
20.88
19.59
Inventory Days
50.80
54.43
50.15
46.55
45.58
45.45
42.89
46.90
50.57
47.41
Payable days
38.50
40.35
41.32
40.83
44.81
47.89
44.12
40.39
37.33
32.94
Cash Conversion Cycle
40.26
41.62
35.41
29.68
22.84
21.74
20.47
26.23
34.12
34.06
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
Interest Cover
94.95
166.95
172.62
179.60
167.11
113.30
71.41
124.23
122.88
122.86

News Update:


  • FDC to expand production capacity by installation of additional BFS Machine
    31st Dec 2020, 12:19 PM

    The company's estimated cost towards the enhancement of production capacity at the above mentioned plant would be around Rs 74 crore at first stage and around Rs 26 crore at later stage

    Read More
  • FDC reports 63% rise in Q2 consolidated net profit
    9th Nov 2020, 11:51 AM

    Total income of the company increased by 7.55% at Rs 390.43 crore for Q2FY21

    Read More
  • FDC - Quarterly Results
    8th Nov 2020, 18:04 PM

    Read More
  • FDC introduces stronger versions of Favipiravir Drugs PiFLU, Favenza
    30th Oct 2020, 15:06 PM

    The 800mg version of the drugs will help reduce the number of tablets to be taken by any patient by 75%

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.